VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Reimbursement Specialist

Johnson & Johnson is a leader in healthcare innovation, dedicated to developing treatments and pioneering solutions that profoundly impact health for humanity. The Reimbursement Specialist will manage payer inquiries, conduct benefit investigations, and address coverage challenges while collaborating with internal and external stakeholders to support the patient service program.

Sign up with Google

Sign in with Google